Clinical mastitis in dairy cows after 'blitz' therapy.
Bradley
A J
AJ
Green
M J
MJ
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002417:Cattle; D015169:Colony Count, Microbial; D004917:Erythromycin / Q000009:adverse effects* / Q000627:therapeutic use; D004926:Escherichia coli / Q000254:growth & development / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000139:chemically induced / Q000382:microbiology / Q000662:veterinary*; D005260:Female; D015994:Incidence; D008321:Mammary Glands, Animal / Q000382:microbiology; D008414:Mastitis, Bovine / Q000139:chemically induced* / Q000453:epidemiology* / Q000382:microbiology; D006113:United Kingdom / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D004917:Erythromycin